Causes and Symptoms

A Real Illness Without a Single Answer

Myalgic encephalomyelitis/chronic fatigue syndrome — ME/CFS — is a serious, often profoundly disabling illness that can strip people of their careers, social lives, and independence. It is not a mood disorder, not a personality quirk, and emphatically not "just tiredness." Yet for all the hardship it causes, science has not yet landed on a single confirmed cause. What researchers increasingly believe is that ME/CFS is likely the final common pathway of several converging factors: a genetic susceptibility meeting one or more biological triggers at an unlucky moment in a person's life.

That uncertainty is frustrating for patients and clinicians alike, but it does not mean the illness is mysterious in a hand-wavy sense. Specific biological abnormalities — in immune function, the nervous system, and cellular metabolism — have been documented in peer-reviewed research indexed across databases such as PubMed and Scopus. Groups including the National Centre for Neuroimmunology and Emerging Diseases (NCNED) at Griffith University in Queensland, Australia, led by researchers such as Don Staines, have identified measurable abnormalities in calcium ion channels and immune signalling that point firmly toward a biological, not psychological, basis for the disease. The science is incomplete, but the direction of travel is clear.

Suspected Triggers: Viruses, Immunity, and More

The most widely recognised trigger is an acute infectious illness. A substantial number of patients report that ME/CFS began after a flu-like episode or a confirmed viral infection — sometimes with striking precision: they got sick, and they never fully recovered. Two viruses that have attracted particular research attention are Epstein-Barr virus (the herpesvirus responsible for glandular fever, or infectious mononucleosis) and human herpesvirus 6 (HHV-6). Neither has been confirmed as a definitive cause; rather, they appear in some patients' histories and immune profiles with enough frequency to remain active areas of investigation. Importantly, the scale of interest in viral triggers accelerated after large numbers of people developed ME/CFS-like illness following COVID-19 infection — a phenomenon now widely discussed as Long COVID — lending the field renewed urgency and funding.

Beyond viruses, several other biological threads have been pulled. Immune dysfunction is one of the most consistently reported findings: abnormal cytokine levels, natural killer cell impairment, and chronic low-grade inflammation appear across many patient cohorts. Whether these immune changes ignite the illness or are themselves produced by something else remains an open question — the chicken-and-egg problem that haunts much of this research. Hormonal dysregulation involving the hypothalamic-pituitary-adrenal (HPA) axis has also been documented; the body's stress-response machinery appears, in at least some patients, to be running out of calibration. And there is evidence that difficulty regulating the physiological response to stress — not emotional stress in a dismissive sense, but the measurable biochemical kind — may be a contributing vulnerability.

Demographics offer another partial clue. ME/CFS is most commonly diagnosed in people in their 40s and 50s, and women receive diagnoses more often than men. Researchers caution, however, that the gender gap may partly reflect differences in health-seeking behaviour and clinical recognition rather than true biological prevalence.

The Three Core Symptoms — and Why They Matter

Because ME/CFS has no blood test or scan that confirms it, diagnosis rests on a careful clinical assessment of the symptom picture. Current diagnostic criteria — most clinicians now use those developed through the National Institutes of Health-convened expert process — require all three of the following core features to be present:

First, a substantially reduced ability to carry out activities that were normal before the illness, persisting for six months or more, accompanied by fatigue not explained by ongoing exertion or relieved by rest. This is not ordinary tiredness after a bad week; it is a collapse of functional capacity that endures.

Second, post-exertional malaise (PEM) — arguably the most defining feature of ME/CFS, and the one most commonly misunderstood by clinicians unfamiliar with the condition. PEM is a worsening of symptoms — fatigue, sore throat, headache, cognitive difficulties, and more — triggered by physical or mental exertion that would previously have been unremarkable. Crucially, the crash does not always arrive immediately; it can be delayed by 12 to 48 hours, and it can persist for days or even weeks. This is why well-intentioned advice to "push through" is not only unhelpful but potentially harmful.

Third, unrefreshing sleep: the profound experience of waking after a full night and feeling no better — sometimes worse — than before lying down. This is not insomnia per se (though difficulty falling or staying asleep is also common); it is a fundamental failure of sleep to restore.

To meet diagnostic criteria, a patient must also exhibit at least one of two additional features: cognitive impairment (the notorious "brain fog" — problems with memory, concentration, and word-finding that can be measurably severe on neuropsychological testing) or orthostatic intolerance (dizziness, lightheadedness, or visual changes triggered by sitting or standing upright, reflecting dysfunction in the autonomic nervous system).

Beyond these required criteria, a range of associated symptoms is commonly reported: muscle pain, joint pain without swelling or redness, frequent sore throat, and swollen or tender lymph nodes in the neck or armpits. No two patients present identically, which adds to the diagnostic challenge.

Why Diagnosis Is So Difficult

ME/CFS follows a relapsing-remitting pattern: symptoms may ease during better periods and return — sometimes with full force — after exertion, infection, stress, or for no obvious reason at all. This unpredictability can mislead both clinicians and patients. A person may appear entirely well at a clinic appointment but be bedridden the following day.

The absence of obvious physical signs makes diagnosis particularly hard. Unlike conditions where a blood panel flags the problem immediately, ME/CFS is currently diagnosed by clinical judgement: a thorough history, careful exclusion of other conditions that could explain the symptoms (thyroid disease, anaemia, sleep apnoea, autoimmune conditions, and others), and a detailed assessment of whether the full symptom picture fits established criteria. This process is called ruling out, and it requires patience and clinical skill. Community organisations such as the ME/CFS/FM Support Association Queensland and patient-advocacy publications including Health Rising and Phoenix Rising have long documented how frequently patients wait years before receiving a correct diagnosis.

One point bears emphasising for anyone reading this and recognising their own experience: self-diagnosis is not reliable. The symptom overlap between ME/CFS and several other serious conditions means that only a qualified clinician — ideally one with experience in this illness — can determine whether the full picture justifies that diagnosis. If you are struggling, the starting point is an honest, detailed conversation with your doctor, armed with as complete a symptom history as you can provide.